Back
Foghorn Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
FHTX
Foghorn Therapeutics, Inc.
Last Price:
$5.35
Seasonality Move:
-23.21%
7 Day Trial
ALL ACCESS PASS
$
7
Foghorn Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Foghorn Therapeutics, Inc. has on average historically fallen by 19.8% based on the past 4 years of stock performance.
-
Foghorn Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Foghorn Therapeutics, Inc. Stock Undervalued?The current Foghorn Therapeutics, Inc. [FHTX] share price is $5.40. The Score for FHTX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
FHTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Foghorn Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Foghorn Therapeutics, Inc. has on average historically fallen by 19.8% based on the past 4 years of stock performance.
Foghorn Therapeutics, Inc. Stock Rating
Buy
51
Foghorn Therapeutics, Inc. (FHTX)
is a Buy
Is Foghorn Therapeutics, Inc. overpriced?
-
Foghorn Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Foghorn Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
foghorntx.com
52-Week Data
52-Week High:
6.79
52-Week Low:
2.94
Prediction Charts
Market Cap:
305.4M
Price in USD:
5.40
Volume:
73.4K
Beta:
3.02
Technical Analysis
SMA50:
4.46
SMA100:
4.73
SMA200:
4.62
52-Wk Change:
7.57%
Stock Predictions
-
Is Foghorn Therapeutics, Inc. stock public?Yes, Foghorn Therapeutics, Inc. is a publicly traded company.
-
What is the Foghorn Therapeutics, Inc. stock quote today?The Foghorn Therapeutics, Inc. stock price is 5.40 USD today.
-
How to buy Foghorn Therapeutics, Inc. stock online?You can buy Foghorn Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-4 | 4.56 | 4.58 | 4.81 | 4.50 |
| Dec-5 | 4.63 | 4.36 | 4.82 | 4.35 |
| Dec-8 | 4.43 | 4.45 | 4.63 | 4.33 |
| Dec-9 | 4.42 | 4.37 | 4.53 | 4.35 |
| Dec-10 | 4.36 | 4.45 | 4.55 | 4.36 |
| Dec-11 | 4.45 | 4.48 | 4.59 | 4.41 |
| Dec-12 | 4.53 | 4.44 | 4.55 | 4.43 |
| Dec-15 | 4.48 | 4.37 | 4.50 | 4.30 |
| Dec-16 | 4.35 | 4.48 | 4.52 | 4.21 |
| Dec-17 | 4.51 | 4.64 | 4.90 | 4.44 |
| Dec-18 | 4.86 | 5.00 | 5.24 | 4.69 |
| Dec-19 | 5.13 | 5.24 | 5.55 | 5.13 |
| Dec-22 | 5.32 | 5.78 | 5.95 | 5.32 |
| Dec-24 | 5.49 | 5.40 | 5.54 | 5.25 |
Foghorn Therapeutics, Inc. Earnings
Foghorn Therapeutics, Inc. Earnings Report: Per Share Foghorn Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Foghorn Therapeutics, Inc. Forecast Revenue Growth
Foghorn Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Foghorn Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.10 per share.
* Foghorn Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.